Semi-Annual Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7580405

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,468,048,000 JPY
Interest and dividends received
63,000 JPY
Income taxes paid
-3,670,000 JPY
Net cash provided by (used in) operating activities
-1,457,571,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-173,164,000 JPY
Loan advances
-8,200,000 JPY
Proceeds from collection of loans receivable
10,000,000 JPY
Net cash provided by (used in) investing activities
-185,115,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
15,810,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,626,876,000 JPY
Cash and cash equivalents
4,901,177,000 JPY
6,528,053,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.